Ortuno-Gutierrez, Nimer
Baco, Abdallah
Braet, Sofie
Younoussa, Assoumani
Mzembaba, Aboubacar
Salim, Zahara
Amidy, Mohamed
Grillone, Saverio
de Jong, Bouke C.
Richardus, Jan Hendrik
Hasker, Epco
Funding for this research was provided by:
R2STOP (R2STOP-COMLEP)
Article History
Received: 11 October 2018
Accepted: 21 May 2019
First Online: 7 June 2019
Ethics approval and consent to participate
: This study was part of a larger study for which ethical approval was obtained from the ethics committee of the university hospital in Antwerp, Belgium (Belgian registration nr. B300201731571), as well as from an ethics committee on Anjouan (N°17–16/CSB.CS.PG.DH/COM 12/07/2017). All subjects provided verbal consent for screening which was carried out by the national leprosy control program as part of their active case finding strategy. Leprosy patients identified were enrolled in the main study (reported separately) after providing written informed consent. In case of illiterate individuals, a thumb print and a signature of an independent witness were sought. For minors below the age of 18 years, a parent or guardian provided informed consent.
: Not applicable.
: The authors declare that they have no competing interests.